Cover Image
市場調查報告書

計算醫學及藥物研發軟體的全球市場分析:各工具 (軟體,資料庫),各用途 (藥物研發及開發,疾病建模,醫療用影像),各地區

Computational Medicine and Drug Discovery Software Market Analysis: By Tools (Software, Databases); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging) & By Geography - Forecast (2015 - 2020)

出版商 IndustryARC 商品編碼 351092
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
Back to Top
計算醫學及藥物研發軟體的全球市場分析:各工具 (軟體,資料庫),各用途 (藥物研發及開發,疾病建模,醫療用影像),各地區 Computational Medicine and Drug Discovery Software Market Analysis: By Tools (Software, Databases); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging) & By Geography - Forecast (2015 - 2020)
出版日期: 2015年01月05日 內容資訊: 英文 158 Pages
簡介

計算醫學及藥物研發軟體市場,活用了藥學,化學,生物科技,及藥物研發、開發用軟體知識,進行研究指定藥物的藥物動力學所需的各種模式的模擬和演算法的開發。驅使各種生物資訊學工具的疾病建模,藥物設計與開發近幾年擴大,導致該市場成長。

本報告提供全球計算醫學及藥物研發軟體市場現狀與今後的市場成長預測,各工具,各用途趨勢,各地區分析,以及打入市場的主要企業簡介彙整。

第1章 市場概要

第2章 摘要整理

第3章 市場情況

  • 市場佔有率分析
  • 競爭分析
    • 產品基準
    • 終端用戶分析
    • 專利分析
    • 前五名公司財務分析

第4章 市場力量

  • 推動市場的要素
  • 市場抑制力
  • 市場課題
  • 該產業的魅力

第5章 策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品生命週期
  • 供應商及經銷商

第6章 各工具

  • 簡介
  • 資料庫
  • 軟體
  • 其他

第7章 各用途

  • 簡介
  • 計算物理醫學
  • 藥物研發、開發
  • 醫療用影像
  • 疾病建模
  • 藥物標的的預測分析
  • 細胞模擬
  • 模擬軟體
  • 其他

第8章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 市場熵

  • 新產品上市
  • 合併、收購,聯合,聯盟,合資企業

第10章 投資的機會

第11章 企業簡介

第12章 附錄

目錄

The computational medicine and drug discovery software market encompasses the use of pharmacy, chemistry, biotechnology and software knowledge for drug discovery and development. This is accompanied by development of algorithms and simulation of various models to study the pharmacokinetics and pharmacodynamics of a particular drug.

The global market for computational medicine and drug discovery software is valued at $X billion in 2014 and is projected to grow with a healthy double digit CAGR of XX% through 2020. Recent growth in disease modeling, drug designing and development by leveraging various bioinformatics tools will lead to the market growth during the period under study (2014-2020).

As of 2014, the application of computational medicine in simulation of cells is estimated to grow at the fastest pace, due to the increasing research activities on sequencing of proteins to design and develop customized medicines suited to an individual's needs. Drug discovery, development and disease modeling applications occupy the highest market share owing to the widespread drug development approaches adopted by several major pharmaceutical companies.

The North America, led by the U.S. accounted for the largest market share in the global market for computational medicine and drug discovery software, occupying over 55% of the revenue in 2014. The huge market size can be credited to the increasing investments in R&D activities pertaining to drug discovery and development and disease modelling.

Table of Contents

1. Global Computational Medicine and Drug Discovery Software Market Overview

2. Executive Summary

3. Global Computational Medicine and Drug Discovery Software Market Landscape

  • 3.1. Market share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End-User Profiling
    • 3.2.3. Patent Analysis
    • 3.2.4. Top 5 Financial Analysis

4. Global Computational Medicine and Drug Discovery Software - Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Computational Medicine and Drug Discovery Software Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunity Analysis
  • 5.4. Product Life Cycle Analysis
  • 5.5. Suppliers & Distributors

6. Global Computational Medicine and Drug Discovery Software Market - By Tools

  • 6.1. Introduction
  • 6.2. Databases
  • 6.3. Software
  • 6.4. Others

7. Global Computational Medicine and Drug Discovery Software Market - By Application

  • 7.1. Introduction
  • 7.2. Computational Physiological Medicine
  • 7.3. Drug Discovery and Development
  • 7.4. Medical Imaging
  • 7.5. Disease Modelling
  • 7.6. Predictive Analysis of Drug Targets
  • 7.7. Cellular Simulation
  • 7.8. Simulation Software
  • 7.9. Others

8. Global Computational Medicine and Drug Discovery Software Market - By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. U.K.
    • 8.3.2. Germany
    • 8.3.3. Netherlands
    • 8.3.4. Norway
    • 8.3.5. Italy
    • 8.3.6. Others
  • 8.4. APAC
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. Korea
    • 8.4.4. Australia
    • 8.4.5. Others
  • 8.5. RoW

9. Market Entropy

  • 9.1. New Product Launches
  • 9.2. M&As, Collaborations, Partnerships & JVs

10. Investment Opportunities

11. Company Profiles

  • 11.1. Aurora Fine Chemicals LLC
  • 11.2. Biognos AB
  • 11.3. Certara, L.P.
  • 11.4. Chemical Computing Group Inc.
  • 11.5. CLC bio
  • 11.6. Collaborative Drug Discovery, Inc.
  • 11.7. Compugen Ltd.
  • 11.8. Crown Bioscience Inc.
  • 11.9. Dassault Systemes, BIOVIA Corp.
  • 11.10. Domainex Ltd
  • 11.11. Entelos, Inc.
  • 11.12. Genedata AG
  • 11.13. Leadscope, Inc.
  • 11.14. Nimbus Therapeutics
  • 11.15. Prosarix Ltd
  • 11.16. Quant Med LLC
  • 11.17. Quantum Pharmaceuticals
  • 11.18. Rhenovia Pharma Limited
  • 11.19. Simulations Plus, Inc.
  • 11.20. Schrodinger, LLC

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top